178 related articles for article (PubMed ID: 11796243)
1. Sphingomyelinase activity of LDL: a link between atherosclerosis, ceramide, and apoptosis?
Kinnunen PK; Holopainen JM
Trends Cardiovasc Med; 2002 Jan; 12(1):37-42. PubMed ID: 11796243
[TBL] [Abstract][Full Text] [Related]
2. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.
Schissel SL; Tweedie-Hardman J; Rapp JH; Graham G; Williams KJ; Tabas I
J Clin Invest; 1996 Sep; 98(6):1455-64. PubMed ID: 8823312
[TBL] [Abstract][Full Text] [Related]
3. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.
Schissel SL; Jiang X; Tweedie-Hardman J; Jeong T; Camejo EH; Najib J; Rapp JH; Williams KJ; Tabas I
J Biol Chem; 1998 Jan; 273(5):2738-46. PubMed ID: 9446580
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and activation of the sphingomyelin-ceramide pathway induced by oxidized low density lipoproteins are not causally related in ECV-304 endothelial cells.
Escargueil-Blanc I; Andrieu-Abadie N; Caspar-Bauguil S; Brossmer R; Levade T; Nègre-Salvayre A; Salvayre R
J Biol Chem; 1998 Oct; 273(42):27389-95. PubMed ID: 9765267
[TBL] [Abstract][Full Text] [Related]
5. Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet.
Deevska GM; Sunkara M; Morris AJ; Nikolova-Karakashian MN
Biosci Rep; 2012 Oct; 32(5):479-90. PubMed ID: 22712892
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein aggregation is inhibited by apolipoprotein J-derived mimetic peptide D-[113-122]apoJ.
Rivas-Urbina A; Rull A; Montoliu-Gaya L; Pérez-Cuellar M; Ordóñez-Llanos J; Villegas S; Sánchez-Quesada JL
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158541. PubMed ID: 31672573
[TBL] [Abstract][Full Text] [Related]
7. The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation.
Augé N; Andrieu N; Nègre-Salvayre A; Thiers JC; Levade T; Salvayre R
J Biol Chem; 1996 Aug; 271(32):19251-5. PubMed ID: 8702606
[TBL] [Abstract][Full Text] [Related]
8. Role of ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells.
Loidl A; Claus R; Ingolic E; Deigner HP; Hermetter A
Biochim Biophys Acta; 2004 Oct; 1690(2):150-8. PubMed ID: 15469904
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic roles of lipoprotein lipase and sphingomyelinase in low density lipoprotein aggregation.
Walters MJ; Wrenn SP
J Colloid Interface Sci; 2011 Nov; 363(1):268-74. PubMed ID: 21839462
[TBL] [Abstract][Full Text] [Related]
10. Sphingomyelinase activity associated with human plasma low density lipoprotein.
Holopainen JM; Medina OP; Metso AJ; Kinnunen PK
J Biol Chem; 2000 Jun; 275(22):16484-9. PubMed ID: 10828058
[TBL] [Abstract][Full Text] [Related]
11. Neutral sphingomyelinase: past, present and future.
Chatterjee S
Chem Phys Lipids; 1999 Nov; 102(1-2):79-96. PubMed ID: 11001563
[TBL] [Abstract][Full Text] [Related]
12. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S
Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585
[TBL] [Abstract][Full Text] [Related]
13. Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis.
Birbes H; El Bawab S; Hannun YA; Obeid LM
FASEB J; 2001 Dec; 15(14):2669-79. PubMed ID: 11726543
[TBL] [Abstract][Full Text] [Related]
14. Effect of sphingomyelinase-mediated generation of ceramide on aggregation of low-density lipoprotein.
Walters MJ; Wrenn SP
Langmuir; 2008 Sep; 24(17):9642-7. PubMed ID: 18671414
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation.
Nguyen SD; Javanainen M; Rissanen S; Zhao H; Huusko J; Kivelä AM; Ylä-Herttuala S; Navab M; Fogelman AM; Vattulainen I; Kovanen PT; Öörni K
J Lipid Res; 2015 Jun; 56(6):1206-21. PubMed ID: 25861792
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids in atherosclerosis and vascular biology.
Chatterjee S
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1523-33. PubMed ID: 9763522
[TBL] [Abstract][Full Text] [Related]
17. Implication of sphingomyelin/ceramide molar ratio on the biological activity of sphingomyelinase.
Boulgaropoulos B; Amenitsch H; Laggner P; Pabst G
Biophys J; 2010 Jul; 99(2):499-506. PubMed ID: 20643068
[TBL] [Abstract][Full Text] [Related]
18. Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis.
Deigner HP; Claus R; Bonaterra GA; Gehrke C; Bibak N; Blaess M; Cantz M; Metz J; Kinscherf R
FASEB J; 2001 Mar; 15(3):807-14. PubMed ID: 11259399
[TBL] [Abstract][Full Text] [Related]
19. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol.
Maor I; Mandel H; Aviram M
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1378-87. PubMed ID: 7670952
[TBL] [Abstract][Full Text] [Related]
20. Modified low density lipoprotein delivers substrate for ceramide formation and stimulates the sphingomyelin-ceramide pathway in human macrophages.
Kinscherf R; Claus R; Deigner HP; Nauen O; Gehrke C; Hermetter A; Russwurm S; Daniel V; Hack V; Metz J
FEBS Lett; 1997 Mar; 405(1):55-9. PubMed ID: 9094423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
